NAV: 18 Mar 2024 | ₹31.95 |
Min. SIP amount | Not Supported |
Rating | 3 |
Fund size | ₹2,318.65Cr |
1Y | 3Y | 5Y | All | |
---|---|---|---|---|
Fund returns | 55.3% | 20.1% | 25.6% | 24.5% |
Category average | 57.3% | 19.1% | 22.1% | NA |
Rank with in category | 11 | 5 | 1 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 13.87% |
Cipla Ltd. | Healthcare | Equity | 8.20% |
Ipca Laboratories Ltd. | Healthcare | Equity | 8.01% |
Lupin Ltd. | Healthcare | Equity | 7.64% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 7.60% |
Alembic Pharmaceuticals Ltd. | Healthcare | Equity | 5.94% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.90% |
Globus Medical Inc | Healthcare | Forgn. Eq | 4.29% |
Concord Biotech Ltd. | Healthcare | Equity | 3.92% |
Procter & Gamble Health Ltd. | Healthcare | Equity | 3.48% |
Inclusive of GST
Exit load of 0.50% if redeemed within 1 month.
0.005% (from July 1st, 2020)
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |